Evidence map›Paper›PMID 41168968›Full record

ReviewFEBS letters2026

Phosphoinositides in membrane remodeling during infections and cellular stresses.

Carla Alemany, Etienne Morel

Abstract readReview
In one paragraph

Review in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carla AlemanyUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France.
Etienne MorelUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France.ORCID https://orcid.org/0000-0002-4763-4954

Funding

Agence Nationale de la Recherche 22-CE14-0019Agence Nationale de la Recherche ANR-23-CE14-0041-01Fondation pour la Recherche Médicale labélisation équipeprogram "Initiative d'excellence" IdEx Université Paris Cité ANR-18-IDEX-0001
6 · The paper itself

Abstract

Phosphoinositides, a versatile class of phosphorylated phosphatidylinositols, are emerging as central orchestrators of cellular stress responses. Beyond defining the organization and identity of endomembranes, these dynamic lipids act as highly adaptable signaling hubs that integrate diverse stress cues, from nutrient deprivation and mechanical strain to osmotic imbalance and DNA damage. Across evolution-from unicellular organisms to mammals-they drive conserved adaptation programs, including vacuolar remodeling, endosomal trafficking, and autophagosome biogenesis, through a finely tuned metabolism governed by an intricate network of kinases, phosphatases, and regulatory partners. Recent advances uncover how compartment-specific regulation, enzymatic diversity, and organelle crosstalk converge on phosphoinositide signaling, revealing these lipids as not only molecular adaptors but also promising therapeutic entry points in diseases marked by defective stress resolution. This review synthesizes emerging insights into the multifaceted roles of phosphoinositides in mobilizing membranes under stress, with a focus on mechanistic principles and recent research.

Indexed as

Cell MembraneInfectionsPhosphatidylinositolsStress, PhysiologicalAnimalsAutophagyHumansSignal TransductionPhosphatidylinositolsautophagyinfectionmembrane dynamicsmembrane traffickingphosphoinositidesstress response

Identifiers

PMID41168968
PMCPMC13573040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.